Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Michael Friis

Head of Equities

Michael Friis portrait

Coverage

HydractAudientesRealfictionShape RoboticsScape TechnologiesGreenMobilityCurasightOrderYOYOPenneoPhotocatOdicoAgillicBawat Water TechnologiesImperoMapsPeopleNNITNordic SolarScandinavian Medical SolutionsWindowMaster InternationalGomSpace GroupCABA CapitalAscelia PharmaEmbla MedicalBioPortoGubraExpreS2ion Biotech Holding

Latest content

ShowingAll content types

Gubra: ABBV-295 data doesn’t seem that far from Eli Lilly's phase 1 data on Eloralintide

Analyst Comment 2026-03-09 15:57 by Michael Friis
Gubra

Gubra (One-pager): Enters 2026 with three differentiated obesity candidates — pivotal data readouts expected in 2026

Research 2026-03-09 08:29 by Philip Coombes, Michael Friis
Gubra

GomSpace – 7.6 MEUR contract with VirtuaLabs for RF monitoring satellite constellation

Analyst Comment 2026-03-04 14:13 by Michael Friis
GomSpace Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account

Curasight (One-pager): Pivotal data readouts ahead in 2026

Research 2026-03-03 14:25 by Michael Friis
Curasight

MPC Energy Solutions: Recording of preliminary 2025 result presentation

Analyst Comment 2026-02-27 15:13 by Michael Friis
MPC Energy Solutions

Agillic (One-pager) - Strategic reset bearing fruit as earnings momentum continues into 2026

Research 2026-02-26 15:15 by Michael Friis, Victor Skriver
Agillic

Gubra:  CTA submitted for first-in-human study of lead asset GUB-UCN2

Analyst Comment 2026-02-26 08:06 by Michael Friis
Gubra

ExpreS2ion Biotech (One-pager): Progress continues on both pipeline and partner driven programs

Research 2026-02-25 14:19 by Philip Coombes, Michael Friis
ExpreS2ion Biotech Holding

GomSpace (One-pager): Scaling to capture a fast-growing market opportunity

Research 2026-02-25 08:00 by Michael Friis, Victor Skriver
GomSpace Group

Rovsing (One-pager): Near-term headwinds, growing tender activity, and a new ESA cycle ahead

Research 2026-02-19 15:45 by Michael Friis, Victor Skriver
Rovsing
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.